ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,934,978 | +18.3% | 4,193,996 | +14.7% | 0.58% | +26.6% |
Q2 2023 | $72,640,488 | +31.0% | 3,655,787 | +13.0% | 0.46% | +17.9% |
Q1 2023 | $55,431,104 | -2.5% | 3,235,908 | +11.4% | 0.39% | -10.7% |
Q4 2022 | $56,861,711 | +34.3% | 2,905,555 | +9.5% | 0.44% | +30.7% |
Q3 2022 | $42,345,000 | -8.2% | 2,653,202 | -20.9% | 0.34% | -7.4% |
Q2 2022 | $46,143,000 | +32.6% | 3,353,393 | +52.9% | 0.36% | +62.8% |
Q1 2022 | $34,792,000 | -21.8% | 2,193,725 | +7.6% | 0.22% | -15.5% |
Q4 2021 | $44,489,000 | -26.6% | 2,037,991 | +0.6% | 0.26% | -27.7% |
Q3 2021 | $60,572,000 | -34.2% | 2,026,481 | -2.4% | 0.36% | -33.8% |
Q2 2021 | $91,995,000 | +24.6% | 2,077,095 | +24.9% | 0.55% | +20.0% |
Q1 2021 | $73,816,000 | -15.6% | 1,663,652 | +4.3% | 0.46% | -11.6% |
Q4 2020 | $87,469,000 | +155.3% | 1,594,981 | +6.4% | 0.52% | +133.8% |
Q3 2020 | $34,256,000 | -4.4% | 1,498,493 | -12.4% | 0.22% | -9.8% |
Q2 2020 | $35,822,000 | +52.7% | 1,711,501 | +1.8% | 0.25% | +18.8% |
Q1 2020 | $23,456,000 | +29.2% | 1,681,434 | +110.8% | 0.21% | +60.5% |
Q4 2019 | $18,153,000 | +98.2% | 797,596 | +1.5% | 0.13% | +76.7% |
Q3 2019 | $9,158,000 | +8.2% | 786,114 | +39.3% | 0.07% | +14.1% |
Q2 2019 | $8,462,000 | +2205.7% | 564,132 | +3686.1% | 0.06% | +2033.3% |
Q3 2018 | $367,000 | – | 14,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |